Abstract

NUT carcinoma (nuclear protein in testis) is a rare and aggressive malignancy, primarily arising from midline structures, such as the thorax and head and neck. Brain involvement in NUT carcinoma is exceedingly rare, particularly as the initial presentation. This report presents the case of a 40-year-old male who presented with symptoms of trigeminal neuralgia and was later diagnosed with NUT carcinoma involving the brain. This case highlights the diagnostic challenges posed by this malignancy and stresses the importance of considering malignancy in patients with unexplained neurological symptoms.

• 1.   French, C. A., Kutok, J. L., Faquin, W. C., Toretsky, J. A., Antonescu, C. R., Griffin, C. A., & Aster, J. C. (2004). Midline carcinoma of children and young adults with NUT rearrangement. Journal of Clinical Oncology, 22(20), 4135-4139.
• 2.   French, C. A. (2010). Pathogenesis of NUT midline carcinoma. Annual Review of Pathology: Mechanisms of Disease, 5, 247-265.
• 3.   Bishop, J. A., Westra, W. H., & French, C. A. (2021). NUT carcinoma: Review of a distinctively aggressive entity. Head & Neck Pathology, 15(1), 41-49.
• 4.   Bauer, D. E., Mitchell, C. M., Strait, K. M., Lathan, C. S., Stelow, E. B., Luer, S. C., & French, C. A. (2012). Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clinical Cancer Research, 18(20), 5773-5779.
• 5.   Stanton, T. H., & French, C. A. (2009). NUT midline carcinoma: An update on recent advances and therapeutic approaches. Journal of Hematology & Oncology, 2(1), 1-6.
• 6.   Doyle, L. A., & Fletcher, C. D. (2014). NUT midline carcinoma: Recognition and emergence of an aggressive subset of squamous cell carcinoma. Advances in Anatomic Pathology, 21(6), 426-433.
• 7.   Gupta, R. (2020). NUT midline lung carcinoma: A rare case report with literature review. Journal of Thoracic Oncology, 15(3), 523-525.
• 8.   Kakkar, A., Antony, V. M., & Irugu, D. V. K. (2021). NUT Midline Carcinoma: A Series of Five Cases Including One with Unusual Clinical Course. Journal of Clinical Oncology, 39(15), e16022.
• 9.   French, C. A., et al. (2010). NUT Midline Carcinoma: Clinical and Molecular Insights. Cancer Research, 70(18), 6973-6977.
• 10.   Bishop, J. A. et al. (2019). Molecular Genetics of NUT Midline Carcinoma. Histopathology, 75(1), 1-9.
• 11.   Lee, T., Cho, J., Baek, C.-H., et al. (2020). Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review. Head and Neck, 42(10), 2655-2664.
• 12.   French, C. A. (2018). Genomic and therapeutic insights into NUT carcinoma. Nature Reviews Cancer, 18(4), 309-319.
• 13.   Stanton, B. C., & French, C. A. (2009). New therapeutic strategies for NUT midline carcinoma: Progress and challenges. Cancer Treatment Reviews, 35(7), 539-542.
• 14.   Chau, N. G., Ma, C., Danga, K., et al. (2020). NUT carcinoma: An aggressive intrathoracictumor with highly conserved NUTM1 fusion oncogenes. Journal of Clinical Oncology, 38(3), 240-251.

Data Sharing Statement

Funding